| Cosmetic Dermatology |
1 |
0.87 |
| Cosmetics |
0 |
0.68 |
| Acne |
0 |
0.63 |
| Aesthetic Medicine |
0 |
0.63 |
| Dermatitis |
0 |
0.53 |
| Melasma |
0 |
0.29 |
| Pigmentation |
0 |
0.29 |
| Postinflammatory Hyperpigmentation |
0 |
0.29 |
| Skin Care |
0 |
0.29 |
| Skin and Soft Tissue Infection |
0 |
0.24 |
| Toxicology |
0 |
0.16 |
| Adrenal Gland |
0 |
0.14 |
| Depression |
0 |
0.14 |
| Memory Problems |
0 |
0.14 |
| Pregnancy |
0 |
0.12 |
| Adverse Effects |
0 |
0.1 |
| Brain |
0 |
0.1 |
| Contact Dermatitis |
0 |
0.1 |
| Endocrinology |
0 |
0.1 |
| Environmental Medicine |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Gland |
0 |
0.1 |
| Hand |
0 |
0.1 |
| Irritants |
0 |
0.1 |
| Memory |
0 |
0.1 |
| Mercury Toxicity |
0 |
0.1 |
| Mouth |
0 |
0.1 |
| Ochronosis |
0 |
0.1 |
| Pedal |
0 |
0.1 |
| Private Practice |
0 |
0.1 |
| Retinoids |
0 |
0.1 |
| Skin Lightening and Depigmenting Agents |
0 |
0.1 |
| Tremor |
0 |
0.1 |
| COVID-19 |
0 |
0.08 |
| Patient Safety |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |